ABC
HZNP

Associated Banc-Corp’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Associated Banc-Corp’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-71
Closed -$5K – 986
2020
Q4 		$5K Hold
71
– – ﹤0.01% 521
2020
Q3 		$6K Hold
71
– – ﹤0.01% 438
2020
Q2 		$4K Hold
71
– – ﹤0.01% 482
2020
Q1 		$2K Buy
+71
New +$2.4K ﹤0.01% 751

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Associated Banc-Corp's HZNP Position: Q1 2021 in Review

Associated Banc-Corp sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 71 shares — an estimated $5K sold.

Associated Banc-Corp first reported a position in HZNP in Q1 2020 and held it in 4 quarters. The position peaked at $6K in Q3 2020. 516 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

  • Associated Banc-Corp reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 71 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $5K.
  • Associated Banc-Corp first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6K in Q3 2020.
  • 516 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.